Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

14.05
Delayed Data
As of Apr 28
 +0.25 / +1.81%
Today’s Change
7.75
Today|||52-Week Range
35.24
+6.04%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close13.80
Today’s open13.80
Day’s range13.80 - 14.20
Volume1,483,280
Average volume (3 months)1,912,456
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-36.71%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.02+0.39%
ZIOPZIOPHARM Oncology In...-0.47-6.26%
AIMTAimmune Therapeutics...-0.23-1.17%
CORTCorcept Therapeutics...+0.20+2.14%
Data as of 4:05pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts